Skip to Main Content

Sajid A Khan

MD, FACS, FSSO
Associate Professor of Surgery (Oncology); Section Chief, Hepato-Pancreato-Biliary (HPB) and Mixed Tumors; Co-Director of Team Science, Yale Center for Clinical Investigation (YCCI)

Contact Information

Sajid A Khan, MD, FACS, FSSO

Lab Location

  • Brady Memorial Laboratory
    310 Cedar Street, Ste Suite 212
    New Haven, CT, 06510
    Business Office:203.337.8507

Office Location

Mailing Address

  • Surgical Oncology

    PO BOX 208062

    New Haven, CT, 06520-8062

    United States

Research Summary

Dr. Khan is an NIH-funded, well published, surgeon-scientist who seeks to use modern molecular biology to improve our understanding and treatment of patients with gastrointestinal cancers. The Khan lab performs basic scientific investigation and translational research in close collaboration with other experts at the Yale Cancer Center in order to advance the field of oncology. Our lab is currently studying the genetic basis underlying the mechanism of metastasis, in addition to the relationship between sex hormones, metabolite and protein expression on colon cancer patient outcomes. Furthermore, we perform clinical outcomes research in surgery for cancers which arise from the stomach, liver, pancreas, bile duct, small intestine, colon, appendix, and skin. Dr. Khan is also the Principal Investigator at Yale for a national clinical trial sponsored by the Southwest Oncology Group (SWOG) studying colorectal cancer chemoprevention.

Extensive Research Description

Dr. Khan is an NIH-funded, well published, surgeon-scientist who seeks to use modern molecular biology to improve our understanding and treatment of patients with gastrointestinal cancers. The Khan lab performs basic scientific investigation and translational research in close collaboration with other experts at the Yale Cancer Center in order to advance the field of oncology. Our lab is currently studying the genetic basis underlying the mechanism of metastasis, in addition to the relationship between sex hormones, metabolite and protein expression on colon cancer patient outcomes. Furthermore, we perform clinical outcomes research in surgery for cancers which arise from the stomach, liver, pancreas, bile duct, small intestine, colon, appendix, and skin. Dr. Khan is also the Principal Investigator at Yale for a national clinical trial sponsored by the Southwest Oncology Group (SWOG) studying colorectal cancer chemoprevention.


Coauthors

Research Interests

Liver; Molecular Biology; Neoplasm Metastasis; Stomach Neoplasms; Colorectal Neoplasms; Cholangiocarcinoma; Carcinoma, Pancreatic Ductal; Gastrointestinal Stromal Tumors; Translational Medical Research; Metastasectomy

Research Images

Selected Publications

Clinical Trials